A Phase I Study Using Most Closely HLA-matched BK Virus-specific T Lymphocytes for the Treatment of BK Virus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-B)
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Polyomavirus specific T cells ViraCyte (Primary)
- Indications Human polyomavirus infections
- Focus Adverse reactions
- Sponsors ViraCyte
- 31 Oct 2016 Planned initiation date changed from 1 Mar 2016 to 1 Jan 2017.
- 05 Feb 2016 Planned initiation date changed from 1 Jan 2016 to 1 Mar 2016, as reported by ClinicalTrials.gov.
- 10 Dec 2015 Planned initiation date changed from 1 Oct 2015 to 1 Jan 2016.